Monoamine Oxidase Inhibitors in Depression: History and Mythology
- 1 May 1990
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 4 (3) , 136-139
- https://doi.org/10.1177/026988119000400307
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- TREATMENT OF HOSPITALIZED DEPRESSED AND SCHIZOPHRENIC PATIENTS WITH MONOAMINE OXIDASE INHIBITORS: INCLUDING REFLECTIONS ON PARGYLINE*Annals of the New York Academy of Sciences, 1963
- A UNIQUE MONOAMINE OXIDASE INHIBITOR FOR DEPRESSIONAmerican Journal of Psychiatry, 1961
- III. The Effect of Isoniazid and of Iproniazid in Patients with Rheumatoid ArthritisCleveland Clinic Journal of Medicine, 1957
- FURTHER STUDIES ON IPRONIAZID PHOSPHATEJournal of Nervous & Mental Disease, 1956
- THE PSYCHIATRIC SIDE-EFFECTS OF IPRONIAZIDAmerican Journal of Psychiatry, 1956
- THE EFFECT OF 1-ISONICOTYNL 2-ISOPROPYL HYDRAZIDE (IIH) ON THE BEHAVIOR OF LONG-TERM MENTAL PATIENTSJournal of Nervous & Mental Disease, 1953
- Synthetic tuberculostats. VII. Monoalkyl derivatives of isonicotinyhydrazineThe Journal of Organic Chemistry, 1953
- In vivo Inhibition of Liver and Brain Monoamine Oxidase by 1-Isonicotinyl-2-Isopropyl Hydrazine.Experimental Biology and Medicine, 1952
- Influence of isonicotinic acid hydrazide (INH) and 1-isonicotinyl-2-isopropyl hydrazide (IIH) on bacterial and mammalian enzymesCellular and Molecular Life Sciences, 1952